BMS-582664

· Bristol-Myers Squibb

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for BMS-582664, covering 2008-11-04 to 2023-12-01. Get the full timeline:

Most recent: Clinical Trial Update: A Phase II Open Label Study of BMS-582664 in Locally Advanced or Metastatic Hepatocellular Cancer [Phase 2]